108 related articles for article (PubMed ID: 15721993)
1. Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia: results of a placebo-controlled double-blind study.
Bergemann N; Mundt C; Parzer P; Pakrasi M; Eckstein-Mannsperger U; Haisch S; Salbach B; Klinga K; Runnebaum B; Resch F
Schizophr Res; 2005 May; 74(2-3):125-34. PubMed ID: 15721993
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and comprehension of metaphoric speech in women suffering from schizophrenia: results of a double-blind, placebo-controlled trial.
Bergemann N; Parzer P; Jaggy S; Auler B; Mundt C; Maier-Braunleder S
Schizophr Bull; 2008 Nov; 34(6):1172-81. PubMed ID: 18156639
[TBL] [Abstract][Full Text] [Related]
3. Testosterone and gonadotropins but not estrogen associated with spatial ability in women suffering from schizophrenia: a double-blind, placebo-controlled study.
Bergemann N; Parzer P; Kaiser D; Maier-Braunleder S; Mundt C; Klier C
Psychoneuroendocrinology; 2008 May; 33(4):507-16. PubMed ID: 18343039
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial.
Akhondzadeh S; Nejatisafa AA; Amini H; Mohammadi MR; Larijani B; Kashani L; Raisi F; Kamalipour A
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):1007-12. PubMed ID: 14499318
[TBL] [Abstract][Full Text] [Related]
5. Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study.
Louzã MR; Marques AP; Elkis H; Bassitt D; Diegoli M; Gattaz WF
Schizophr Res; 2004 Feb; 66(2-3):97-100. PubMed ID: 15061241
[TBL] [Abstract][Full Text] [Related]
6. Combination of estrogen and antipsychotics in the treatment of women with chronic schizophrenia: a double-blind, randomized, placebo-controlled clinical trial.
Ghafari E; Fararouie M; Shirazi HG; Farhangfar A; Ghaderi F; Mohammadi A
Clin Schizophr Relat Psychoses; 2013 Jan; 6(4):172-6. PubMed ID: 23302446
[TBL] [Abstract][Full Text] [Related]
7. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
Akhondzadeh S; Safarcherati A; Amini H
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics.
Bergemann N; Mundt C; Parzer P; Jannakos I; Nagl I; Salbach B; Klinga K; Runnebaum B; Resch F
Schizophr Res; 2005 Mar; 73(2-3):357-66. PubMed ID: 15653282
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia.
Emsley R; Chiliza B; Asmal L; du Plessis S; Phahladira L; van Niekerk E; van Rensburg SJ; Harvey BH
Schizophr Res; 2014 Sep; 158(1-3):230-5. PubMed ID: 24996507
[TBL] [Abstract][Full Text] [Related]
10. Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.
Artaloytia JF; Arango C; Lahti A; Sanz J; Pascual A; Cubero P; Prieto D; Palomo T
Am J Psychiatry; 2006 Mar; 163(3):488-93. PubMed ID: 16513871
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia: a double-blind, randomized, placebo-controlled study.
Zhang ZJ; Kang WH; Li Q; Wang XY; Yao SM; Ma AQ
Schizophr Res; 2006 Dec; 88(1-3):102-10. PubMed ID: 16959472
[TBL] [Abstract][Full Text] [Related]
12. Abnormally rapid reversal learning and reduced response to antipsychotic drugs following ovariectomy in female rats.
Arad M; Weiner I
Psychoneuroendocrinology; 2012 Feb; 37(2):200-12. PubMed ID: 21723667
[TBL] [Abstract][Full Text] [Related]
13. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
[TBL] [Abstract][Full Text] [Related]
14. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
[TBL] [Abstract][Full Text] [Related]
15. Estrogens and men with schizophrenia: is there a case for adjunctive therapy?
Kulkarni J; de Castella A; Headey B; Marston N; Sinclair K; Lee S; Gurvich C; Fitzgerald PB; Burger H
Schizophr Res; 2011 Feb; 125(2-3):278-83. PubMed ID: 21062669
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia: A Randomized Clinical Trial.
Berwaerts J; Liu Y; Gopal S; Nuamah I; Xu H; Savitz A; Coppola D; Schotte A; Remmerie B; Maruta N; Hough DW
JAMA Psychiatry; 2015 Aug; 72(8):830-9. PubMed ID: 25820612
[TBL] [Abstract][Full Text] [Related]
17. A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia.
Lee BJ; Lee JG; Kim YH
J Psychopharmacol; 2007 Jun; 21(4):421-7. PubMed ID: 17092979
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.
Shim JC; Shin JG; Kelly DL; Jung DU; Seo YS; Liu KH; Shon JH; Conley RR
Am J Psychiatry; 2007 Sep; 164(9):1404-10. PubMed ID: 17728426
[TBL] [Abstract][Full Text] [Related]
19. Alprazolam as a neuroleptic adjunct in the emergency treatment of schizophrenia.
Barbee JG; Mancuso DM; Freed CR; Todorov AA
Am J Psychiatry; 1992 Apr; 149(4):506-10. PubMed ID: 1348161
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
Citrome L; Meng X; Hochfeld M; Stahl SM
Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
